Literature DB >> 25714978

Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease.

Beatrice Macchi1, Rosanna Di Paola, Francesca Marino-Merlo, Maria Rosa Felice, Salvatore Cuzzocrea, Antonio Mastino.   

Abstract

Evidence has been accumulated showing that inflammatory and cell death pathways are altered both in brain and periphery during Parkinson disease (PD). Neuronal loss in PD is associated with chronic neuroinflammation characterized by microglia activation through the release of reactive oxygen radicals, cytokines, and Prostaglandin E2. The release of these inflammatory mediators in addition to deprivation in growth factors and increase of calcium and dopamine seem implicated in triggering apoptosis. The interaction of leucine-rich repeat kinase and Fas- Associated protein with Death Domain has been implicated in the switching-on of the extrinsic apoptotic pathway via caspase-8 activation, while deficiency in PTEN induced putative kinase 1 has been shown to cause Ca2+ accumulation in mitochondria, increased generation of reactive oxygen species and intrinsic cell death. Autophagy/mitophagy appears to be impaired in the brain during PD; this impairment could be related to defective degradation of mutant α-synuclein and consequent apoptotic cell death. Regarding the peripheral blood, reduced amounts of dopamine, reduced levels of immunoreactivity for tyrosine hydroxylase and dopamine active transporter, and alterations of dopamine receptor expression have been detected in mononuclear cells from PD patients. In addition, mononuclear cells from PD patients show mitochondrial, ubiquitin-proteasome system dysfunction and up-regulation of α-synuclein gene, associated to high expression of the Fas molecule, activation of caspase-3 and -9 and proneness to apoptosis. These and other observations reported in this mini-review suggest that a better understanding of molecular dysfunctions in inflammatory and cell death/autophagy pathways, both in the brain and peripheral blood, could provide useful targets for future investigation on drug-discovery and biomarker identification in PD.

Entities:  

Mesh:

Year:  2015        PMID: 25714978     DOI: 10.2174/1871527314666150225124928

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  37 in total

1.  The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats.

Authors:  Zhijuan Mao; Chanchan Liu; Suqiong Ji; Qingmei Yang; Hongxiang Ye; Haiyan Han; Zheng Xue
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

Review 2.  Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease.

Authors:  Masoomeh Khalifeh; George E Barreto; Amirhossein Sahebkar
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

3.  SO4= uptake and catalase role in preconditioning after H2O2-induced oxidative stress in human erythrocytes.

Authors:  Rossana Morabito; Alessia Remigante; Maria Letizia Di Pietro; Antonino Giannetto; Giuseppina La Spada; Angela Marino
Journal:  Pflugers Arch       Date:  2016-12-17       Impact factor: 3.657

4.  From the Cover: Alterations in Optineurin Expression and Localization in Pre-clinical Parkinson's Disease Models.

Authors:  John Pierce Wise; Jason Cannon
Journal:  Toxicol Sci       Date:  2016-07-29       Impact factor: 4.849

5.  Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.

Authors:  Shao-Hua Su; Yi-Fang Wu; Qi Lin; Jian Hai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-19       Impact factor: 3.000

6.  Anion exchange through band 3 protein in canine leishmaniasis at different stages of disease.

Authors:  Rossana Morabito; Alessia Remigante; Mauro Cavallaro; Alessandro Taormina; Giuseppina La Spada; Angela Marino
Journal:  Pflugers Arch       Date:  2017-04-05       Impact factor: 3.657

7.  SMER28 Attenuates Dopaminergic Toxicity Mediated by 6-Hydroxydopamine in the Rats via Modulating Oxidative Burdens and Autophagy-Related Parameters.

Authors:  Shahram Darabi; Ali Noori-Zadeh; Farzad Rajaei; Hojjat Allah Abbaszadeh; Salar Bakhtiyari; Navid Ahmady Roozbahany
Journal:  Neurochem Res       Date:  2018-10-04       Impact factor: 3.996

Review 8.  Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.

Authors:  Michaela E Johnson; Benjamin Stecher; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  Trends Neurosci       Date:  2018-10-17       Impact factor: 13.837

9.  Decreased serum proNGF concentration in patients with Parkinson's disease.

Authors:  Xiao-Min Xu; Mei-Xue Dong; Xia Feng; Yang Liu; Jun-Xi Pan; Shi-Yu Jia; Du Cao; You-Dong Wei
Journal:  Neurol Sci       Date:  2017-10-19       Impact factor: 3.307

Review 10.  Neuroprotective Potential of Ellagic Acid: A Critical Review.

Authors:  Ashutosh Gupta; Amit Kumar Singh; Ramesh Kumar; Sarah Jamieson; Abhay Kumar Pandey; Anupam Bishayee
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.